 mid-cap
feb pm et
summari develop proprietari product use cardiologist physician heart surgeon
angioplasti heart surgeri procedur
nm price-to-earnings oper ep
risk assess reflect lead posit
vital market -- develop proprietari product
design enabl heart rest heal recov
improv blood flow coronari arteri note
highli innov competit marketplac
may ep estim base cfra oper earn
histor earn report compani report
cash dividend paid last year
past perform indic futur perform reli upon
analysi prepar equiti analyst
feb pm stock trade
look fy fy sale rise
driven
continu robust sale impella
product portfolio particularli impella cp
impella account
sale respect see increas
patient usag aid larger instal base
expand int sale decemb
instal base impella
site impella cp heart pump
look fy fy oper margin
rise basi point
despit increas invest
expans germani japan aid
leverag anticip continu robust
receiv approv japan impella
impella heart pump treatment
drug-resist acut heart failur
octob announc first
patient treat impella heart pump
japan compani open hospit
japan plan control roll-out
project hospit march
think ultim hospit
forecast fy ep fy ep
fy
see among fastest-grow
medic devic compani although jun-q
sept-q sale rose quarterli
sale grown least everi quarter
sinc see continu robust
sale growth least end fy
re-acceler partli aid sale
germani japan see increas
intern sale growth germani
japan receiv approv
impella impella septemb
anticip germani japan
import growth driver share
histor trade premium base
leadership posit robust sale earn
growth think share current
trade forward ep
estim within averag
rang well peer
near fair valu
risk target price recommend
includ failur obtain regulatori approv
product injuri relat use
product lead product liabil lawsuit
product discontinu
target base
above-p ratio line
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
vice-president director busi
 mid-cap
develop manufactur market proprietari product design enabl heart
rest heal recov improv blood flow coronari arteri end-organ and/or temporarili
perform pump function heart compani product use cardiac
catheter lab cath lab intervent cardiologist electrophysiolog lab hybrid lab
heart surgeri suit heart surgeon physician might use compani devic patient
need hemodynam support angioplasti heart surgeri procedur
primari product impella product portfolio includ impella impella cp
impella rp impella ld impella sale gener impella product
march receiv first two pre-market pma approv fda impella
product use elect urgent highrisk percutan coronari intervent pci
commonli known coronari angioplasti simpli angioplasti pma indic impella
product first hemodynam support devic proven safe effect fda indic use
high- risk pci procedur august submit pma supplement expand
impella pma approv includ addit indic includ impella devic impella cp
impella impella ld support left side heart submiss set
indic relat use impella devic patient suffer cardiogen shock follow acut
myocardi infarct cardiac surgeri longer durat support april fda
approv pma supplement impella impella cp impella impella ld heart pump
provid treatment on-going cardiogen shock set impella heart pump stabil
patient hemodynam unload left ventricl perfus end organ allow recoveri
nativ heart impella impella impella ld impella cp impella rp product also ce
mark approv health canada approv market devic european union canada
decemb abl expand pma impella heart pump use high-risk pci
includ impella cp heart pump impella heart pump minim invas treatment option
use stabil patient hemodynam unload left ventricl heart allow
muscl rest recov nativ function
impella product receiv clearanc fda partial circulatori support
six hour compani receiv first two pma approv fda impella
product use elect urgent high-risk pci procedur impella devic ce
mark approv europ five day use approv use approxim countri
compani submit pma supplement request expand impella pma approv
includ addit indic impella product also includ impella devic
impella cp impella impella ld support left side heart submiss
set indic relat use impella devic patient suffer cardiogen shock follow
acut myocardi infarct cardiac surgeri longer durat support fda
approv pma supplement compani impella impella cp impella impella ld heart
pump provid treatment on-going cardiogen shock
septemb instal base impella heart pump site
instal custom base impella cp heart pump site instal base impella rp heart
pump site
compani announc impella cp receiv clearanc fda impella
cp provid blood flow approxim one liter per minut impella primarili
use either intervent cardiologist support patient cath lab surgeon heart
compani submit pma supplement request expand impella pma approv
includ addit indic impella product also includ impella devic
impella cp impella impella ld support left side heart submiss
set indic relat use impella devic patient suffer cardiogen shock follow
acut myocardi infarct cardiac surgeri longer durat support fda
approv pma supplement compani impella impella cp impella impella ld heart
pump provid treatment on-going cardiogen shock
includ recent acquir st jude medic inc heartwar intern inc terumo heart inc
redistribut reproduct prohibit without prior written permiss copyright cfra
 mid-cap
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
overvalu
bullish sinc februari technic indic
bullish
figur base fiscal year-end price
growth rate averag
return equiti
balanc sheet data million
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
 mid-cap
base index
five-year market price perform feb
capit budget amid shift
procedur inpati outpati
includ increas global demand
qualiti health care age popul
rise outlay lead steadi flow
new diagnost therapeut product
 health equip
sub-index increas vs rise
 composit index follow
rise health equip
index vs declin
composit index year date
juli health
equip index rose vs rise
 composit index
note sector sub-industri inform base
past perform indic futur perform
reli upon
fundament outlook health care
equip sub-industri next month
neutral continu view mani product
categori histor recession-resist
expect continu grow albeit
slowli growth procedur rate
slow area normal view
non-elect cardiac rhythm
manag intervent cardiolog
orthoped recent howev equip
maker think certain procedur rate may
stabil start recov
medic devic tax requir
healthcar reform law went effect
januari temporarili
suspend
elect donald trump republican
retain control congress believ
gop abil substanti alter
afford act includ potenti
elimin variou health care sector fee
tax although gop replac
remain uncertain believ
potenti fewer insur patient
neg impact equip sub-industri
fewer insur patient would like lead
fewer procedur anticip
hospit largest buyer
medic equip would also advers
impact could pressur
expect revenu rise constant
currenc mid- upper-singl digit pace
aid new product expans emerg
market case acquisit
still expect extend replac cycl
 hospit area price
demand certain product categori
unfavor foreign exchang continu
hospit becom cautiou regard
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
 mid-cap
analyst research note compani news
rais target price well peer
ratio base fy march ep estim
rais fy ep estim dec-q ep vs
ahead estim sale rose sale
intern sale primarili germani japan smaller base
anticip continu robust growth impella heart pump client base
grow intern market still earli stage see
rais target price well-above-p
ratio base forward ep estim
anticip robust growth next sever year hospit base
expand sept-q ep vs ahead estim sale
rose driven rise impella heart pump sale sale
germani sale albeit small base octob announc
first patient japan treat impella heart pump anticip
japan becom import growth driver /jeffrey loo cfa
et cfra keep hold opinion share inc
rais target well-above-p
ratio base fy ep estim
faster sale earn growth jun-q ep vs ahead
estim sale rose impella heart pump aid
rise germani albeit small base instal hospit base
impella heart pump rose hospit instal base
impella cp heart pump rose encourag
metric see acceler sale germani japan /jeffrey loo cfa
et cfra keep hold opinion share inc
keep target price peer
ratio base fy ep estim faster growth -q
ep vs ahead estim sale rose
impella heart pump sale abmd instal hospit base
impella impella cp heart pump rose hospit
guid fy sale growth oper margin rang
initi fy ep estim see acceler
oversea sale particularli germani japan recent approv
inc keep target
peer in-lin histor level dec-q ep
vs ahead estim rais fy ep
estim sale rose robust impella heart pump sale
rose sale driven increas patient usag
sale outsid rose small base see acceler
oversea sale mainli germani japan instal base impella
heart pump increas hospit bring total instal base
site /jeffrey loo cfa
share hold see among
fastest grow medic devic compani quarterli sale grown least
everi quarter sinc dec-q fy see robust growth
fy aid increas oversea sale germani japan
share trade premium believ share trade next
ep view mid-point average rang
peer near fair valu
target base peer fy fy
ep /jeffrey loo cfa
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
 mid-cap
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share
grow usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
 mid-cap
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut standard
 poor malaysia sdn bhd cfra malaysia certain research distribut
cfra uk limit cfra uk cfra uk cfra malaysia wholly-own
subsidiari cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
